Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John S Allen

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Angiogenesis|August 24, 2014
Angiogenesis and airway reactivity in asthmatic Brown Norway ratsElizabeth M Wagner, John Jenkins, Anne Schmieder, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 11, 2015
Quantifying progression and regression of thrombotic risk in experimental atherosclerosisRohun U Palekar, Andrew P Jallouk, Matthew J Goette, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|October 31, 2015
Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor modelAlison K Esser, Anne H Schmieder, Michael H Ross, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 11, 2012
Programmable nanoparticle functionalization for in vivo targetingHua Pan, Jacob W Myerson, Lingzhi Hu, et al.
Magnetic Resonance in Medicine|February 22, 2005
Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticlesAnne H Schmieder, Patrick M Winter, Shelton D Caruthers, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 11, 2006
Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosisPatrick M Winter, Anne M Neubauer, Shelton D Caruthers, et al.
Angewandte Chemie (International Ed. in English)|November 16, 2010
Computed tomography in color: NanoK-enhanced spectral CT molecular imagingDipanjan Pan, Ewald Roessl, Jens-Peter Schlomka, et al.
Theranostics|January 3, 2017
Anti-angiogenic Nanotherapy Inhibits Airway Remodeling and Hyper-responsiveness of Dust Mite Triggered Asthma in the Brown Norway RatGregory M Lanza, John Jenkins, Anne H Schmieder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2020
VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong SurvivalFrancesca Fontana, Michael J Scott, John S Allen, et al.
Plos One|December 20, 2023
Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targetingFrancesca Fontana, Alison K Esser, Christopher Egbulefu, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Angiogenesis|August 24, 2014
Angiogenesis and airway reactivity in asthmatic Brown Norway ratsElizabeth M Wagner, John Jenkins, Anne Schmieder, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 11, 2015
Quantifying progression and regression of thrombotic risk in experimental atherosclerosisRohun U Palekar, Andrew P Jallouk, Matthew J Goette, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|October 31, 2015
Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor modelAlison K Esser, Anne H Schmieder, Michael H Ross, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 11, 2012
Programmable nanoparticle functionalization for in vivo targetingHua Pan, Jacob W Myerson, Lingzhi Hu, et al.
Magnetic Resonance in Medicine|February 22, 2005
Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticlesAnne H Schmieder, Patrick M Winter, Shelton D Caruthers, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 11, 2006
Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosisPatrick M Winter, Anne M Neubauer, Shelton D Caruthers, et al.
Angewandte Chemie (International Ed. in English)|November 16, 2010
Computed tomography in color: NanoK-enhanced spectral CT molecular imagingDipanjan Pan, Ewald Roessl, Jens-Peter Schlomka, et al.
Theranostics|January 3, 2017
Anti-angiogenic Nanotherapy Inhibits Airway Remodeling and Hyper-responsiveness of Dust Mite Triggered Asthma in the Brown Norway RatGregory M Lanza, John Jenkins, Anne H Schmieder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2020
VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong SurvivalFrancesca Fontana, Michael J Scott, John S Allen, et al.
Plos One|December 20, 2023
Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targetingFrancesca Fontana, Alison K Esser, Christopher Egbulefu, et al.
Pageof 8